Synergistic cytotoxicity of gemcitabine, clofarabine and edelfosine in lymphoma cell lines.

Valdez, B C; Zander, A R; Song, G; Murray, D; Nieto, Y; Li, Y; Champlin, R E; Andersson, B S

Valdez, B C; Zander, A R; Song, G; Murray, D; Nieto, Y; Li, Y; Champlin, R E; Andersson, B S.

Afiliação

Valdez BC; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Zander AR; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Song G; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Murray D; Department of Experimental Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada.
Nieto Y; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Li Y; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Andersson BS; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Blood Cancer J ; 4: e171, 2014 Jan 10.

Article em En | MEDLINE | ID: mdl-24413065

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Blood Cancer J Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Blood Cancer J Ano de publicação: 2014 Tipo de documento: Article